STOCK TITAN

Meiwu Technology Company (WNW) Stock Price, News & Analysis

WNW NASDAQ
Published by Stock Titan Data refreshed

Why is WNW Stock Down Today?

3.65% after hours
1.5x vol
15m delay

Meiwu Technology Co. Ltd. (WNW) reported higher six-month revenue on November 4, but its net loss widened to $15,847,413 from $1,361,018 a year earlier.

AI-generated explanation by Rhea-AI, written on at . How Rhea-AI works. Not financial advice.

Price Move History

Daily moves over 5%
86 252 sessions, November 5, 2025 to November 5, 2026
Largest daily move
+97.1% close of May 19, 2026
1-year change
-98.8% closing prices, November 5, 2025 to November 5, 2026
1-month change
-18.6% closing prices, October 5, 2026 to November 5, 2026

Company Description

Meiwu Technology Company Limited is a British Virgin Islands holding company with China-based operations that currently focuses on the sale of functional skincare products. The company states that it implemented a strategic transition from online sales of selected high-quality food products and short message service activities to the skincare industry, and that its current skincare business is conducted through Xiamen Chunshang Health Technology Co., Ltd., an indirect wholly owned subsidiary in China.

The company's ordinary shares, with no par value, trade on the Nasdaq Capital Market under the symbol WNW. Meiwu was incorporated in the British Virgin Islands on December 4, 2018, and its regulatory filings identify its principal executive office in Xiamen, Fujian, China. As a foreign private issuer, the company furnishes current reports on Form 6-K and has filed capital-markets and corporate-governance disclosures with the U.S. Securities and Exchange Commission.

Business focus

Meiwu's latest company descriptions identify functional skincare as its current operating focus. The business includes sales of functional skincare products through Xiamen Chunshang Health Technology Co., Ltd., with company updates referring to product formulation analysis, ingredient-related research materials, external research collaboration and efforts to expand a functional skincare product portfolio and supply-chain ecosystem.

Earlier company descriptions and reference materials describe Meiwu's prior activities as including an online platform for selected food products, short message service activity and technical services. The company's current public communications emphasize the transition away from those prior activities toward skincare products and related operating initiatives.

Public-company structure and capital markets activity

Meiwu's listed security is ordinary shares rather than American depositary shares. Recent public-company activity has included reverse share splits, Nasdaq minimum bid price compliance notices and equity financing transactions involving ordinary shares and warrants. These matters are separate from the operating business but form part of the company's capital-structure and listing-history record.

The company has used registered direct offering documents and private placement agreements to raise capital through issuances of ordinary shares and related warrants. Its SEC reports also document governance changes, management's discussion and analysis, unaudited interim financial statements and material agreements associated with financing transactions.

Stock Performance

$1.85
-3.65%
-0.07
After hoursChange vs the $1.92 closeLast updated: November 5, 2026 at 18:36
-98.8%
Performance 1 year
$48.7M

Meiwu Technology Company (WNW) closed at $1.92 on November 5, 2026. Over the past 12 months, the price has lost 98.8%.

See what a $1,000 investment in WNW would be worth today

Average down calculator for WNW

WNW Metrics & Rankings

Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.

Financial Highlights

Meiwu Technology Company generated $7.1M in revenue in FY2025, retaining a 10.1% gross margin, operating income reached -$8.8M, and net income was -$18.6M. Diluted earnings per share stood at -$0.82. The company generated $9.0M in operating cash flow. The current ratio was 15.81, measuring current assets divided by current liabilities.

$7.1M
Revenue (FY2025)
-$18.6M
Net Income (FY2025)
$9.0M
Operating Cash Flow

Upcoming Events

MAR
18
March 18, 2027 Financial

Warrant expiration

Warrants issued in the offering have a 1-year term, $2.00 exercise; expiry ~one year after closing (contingent on issuance).

Meiwu Technology Company has 1 upcoming scheduled event. The next event, "Warrant expiration", is scheduled for March 18, 2027 (in 133 days). It is a financing or capital event, such as a dividend or a debt maturity. Investors can track these dates to stay informed about potential catalysts that may affect the WNW stock price.

Short Interest History

Last 12 Months

Short interest in Meiwu Technology Company (WNW) currently stands at 217.5 thousand shares, down 15.8% from the previous reporting period. Since the latest stock split, short interest has increased by 2200.8%, measured from April 2026.

Days to Cover History

Last 12 Months

Days to cover for Meiwu Technology Company (WNW) currently stands at 6.2 days, up 521% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since November 2025, the figure has increased by 521%. Across the settlements charted above, it has ranged from 1.0 to 6.2 days.

WNW Company Profile & Sector Positioning

Meiwu Technology Company (WNW) operates in the Internet Retail industry within the broader Consumer Cyclical sector and is listed on the NASDAQ.

Investors comparing WNW often look at related companies in the same sector, including LightInTheBox Holding Co., Ltd. (LITB), Hour Loop, Inc. (HOUR), ZKH Group Limited (ZKH), Baozun Inc. (BZUN), and Newegg Commerce, Inc. (NEGG). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate WNW's relative position within its industry.

Frequently Asked Questions

The current stock price of Meiwu Technology Company (WNW) is $1.85 in after-hours trading as of November 5, 2026.

The market cap of Meiwu Technology Company (WNW) is approximately $48.7M. Learn more about what market capitalization means .

The FY2025 revenue of Meiwu Technology Company (WNW) is $7.1M, from its most recent completed fiscal year.

The FY2025 net income of Meiwu Technology Company (WNW) is -$18.6M, from its most recent completed fiscal year.

The diluted earnings per share (EPS) of Meiwu Technology Company (WNW) is -$0.82 for FY2025, its most recent completed fiscal year. Learn more about EPS .

The operating cash flow of Meiwu Technology Company (WNW) is $9.0M for FY2025, its most recent completed fiscal year. Learn about cash flow.

The gross profit margin of Meiwu Technology Company (WNW) is 10.1% for FY2025, its most recent completed fiscal year. Learn about gross margins.

The current ratio of Meiwu Technology Company (WNW), current assets divided by current liabilities, was 15.81 at the end of FY2025, its most recent completed fiscal year. Learn about liquidity ratios.

The gross profit of Meiwu Technology Company (WNW) is $714K for FY2025, its most recent completed fiscal year.

The operating income of Meiwu Technology Company (WNW) is -$8.8M for FY2025, its most recent completed fiscal year. Learn about operating income.

Meiwu Technology Company Limited currently focuses on the sale of functional skincare products through Xiamen Chunshang Health Technology Co., Ltd., an indirect wholly owned subsidiary in China.

The company states that it transitioned from online sales of selected high-quality food products and short message service activities to the skincare industry.

Meiwu Technology Company Limited is incorporated in the British Virgin Islands.

The company operates through subsidiaries in China. Its SEC filings identify a principal executive office in Xiamen, Fujian, China.

WNW represents Meiwu Technology Company Limited's ordinary shares, with no par value, listed on the Nasdaq Capital Market.

The company's functional skincare business is conducted through Xiamen Chunshang Health Technology Co., Ltd., an indirect wholly owned subsidiary in China.